Since CaMKs and CREB were also identified as potential proteins with reduced phosphorylation after CN03 treatment in the rd1 model [13], PKG-mediated CaMKs-CREB signaling appears to be a promising target to develop potential biomarkers for retinal disease progression and therapy response. This evidence concerns the gene CREB1 and Abnormal retinal morphology.